Top compounds associated with response to ZFYVE21


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.001
mRNA STF-31 CTRPv2 pan-cancer AAC -0.13 0.001
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.12 0.001
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.13 0.002
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.12 0.002
mRNA Doxorubicin CTRPv2 pan-cancer AAC -0.11 0.002
mRNA paclitaxel gCSI pan-cancer AAC -0.19 0.002
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Docetaxel gCSI pan-cancer AAC -0.19 0.003
Download CSV